Analysis

Remdesivir tied to 54% lower risk of death among hospitalized COVID patients A comparison study based on two large, open-label studies links the antiviral drug remdesivir (Veklury) to a 54% lower risk of all-cause death and shorter hospital stays compared with standard of care (SOC) alone in hospitalized COVID-19 patients requiring supplemental oxygen in 2020.  CIDRAP

...

Three months into bird flu outbreak in U.S. dairy cows, experts see deep-rooted problems in response Three months into the H5N1 bird flu outbreak in U.S. dairy cows, experts see deep-rooted problems in the government's response. Andrew Joseph STAT

Three months since an outbreak of avian influenza in U.S. dairy cattle was declared, the country is failing to take the necessary steps to get in front of the virus and possibly contain its spread among cows, according to interviews with more than a dozen experts and current and former government officials.

Latest XBB COVID-19 vaccine offers protection against hospitalization, deaths Today, JAMA Internal Medicine published a study calculating the protection offered by the latest Pfizer COVID-19 XBB vaccine compared to older vaccines against COVID-associated hospitalization and emergency department (ED) or urgent care (UC) visits.  CIDRAP

...

The authors compared outcomes among those who had received an updated XBB vaccine and those who had not received an XBB vaccine of any kind, regardless of prior COVID-19 vaccination or infection history.